IQVIA Holdings Inc. (0JDM.L)
| Previous close | 229.89 |
| Open | 230.67 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 228.83 - 232.49 |
| 52-week range | 166.94 - 261.42 |
| Volume | |
| Avg. volume | 1,650 |
| Market cap | 45.929B |
| Beta (5Y monthly) | 1.49 |
| PE ratio (TTM) | 0.42 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™
RESEARCH TRIANGLE PARK, N.C., October 02, 2024--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a generative AI technology that enables a step-change enhancement in how life science customers receive timely and powerful insights.
- Business Wire
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
RESEARCH TRIANGLE PARK, N.C., September 19, 2024--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Frost & Sullivan, a leading independent research and consulting firm, has awarded IQVIA with the 2024 Global Customer Value Leadership Award for excellence in the global artificial intelligence (AI) quality and regulatory solutions space for the healthcare industry.
- PR Newswire
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative.
